PubMed

The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.

Kokkonen H, Johansson M, Innala L, Jidell E, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2007;9(3):R56. Erratum in: Arthritis Res Ther. 2007;9(5):403. PMID: 17553139 [PubMed - indexed for MEDLINE]Related articlesFree article

PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease.

Johansson M, Arlestig L, Hallmans G, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2006;8(1):R19.PMID: 16507117 [PubMed - indexed for MEDLINE]Related articlesFree article

Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis.

Orozco G, Pascual-Salcedo D, López-Nevot MA, Cobo T, Cabezón A, Martín-Mola E, Balsa A, Martín J.

Rheumatology (Oxford). 2008 Feb;47(2):138-41. Epub 2007 Dec 21.PMID: 18156150 [PubMed - indexed for MEDLINE]Related articlesFree article

Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.

Goëb V, Dieudé P, Daveau R, Thomas-L'otellier M, Jouen F, Hau F, Boumier P, Tron F, Gilbert D, Fardellone P, Cornélis F, Le Loët X, Vittecoq O.

Rheumatology (Oxford). 2008 Aug;47(8):1208-12. Epub 2008 Jun 5.PMID: 18535030 [PubMed - indexed for MEDLINE]Related articles

Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis.

Michou L, Teixeira VH, Pierlot C, Lasbleiz S, Bardin T, Dieudé P, Prum B, Cornélis F, Petit-Teixeira E.

Ann Rheum Dis. 2008 Apr;67(4):466-70. Epub 2007 Jul 27.PMID: 17660221 [PubMed - indexed for MEDLINE]Related articles

Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients.

Feitsma AL, Toes RE, Begovich AB, Chokkalingam AP, de Vries RR, Huizinga TW, van der Helm-van Mil AH.

Rheumatology (Oxford). 2007 Jul;46(7):1092-5. Epub 2007 Mar 6.PMID: 17341507 [PubMed - indexed for MEDLINE]Related articlesFree article

Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study.

Lie BA, Viken MK, Odegård S, van der Heijde D, Landewé R, Uhlig T, Kvien TK.

Ann Rheum Dis. 2007 Dec;66(12):1604-9. Epub 2007 May 1.PMID: 17472988 [PubMed - indexed for MEDLINE]Related articles

Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma.

Majorczyk E, Jasek M, Płoski R, Wagner M, Kosior A, Pawlik A, Obojski A, Luszczek W, Nowak I, Wiśniewski A, Kuśnierczyk P.

Eur J Hum Genet. 2007 Oct;15(10):1043-8. Epub 2007 Jun 20.PMID: 17579671 [PubMed - indexed for MEDLINE]Related articlesFree article

Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.

Karlson EW, Chibnik LB, Cui J, Plenge RM, Glass RJ, Maher NE, Parker A, Roubenoff R, Izmailova E, Coblyn JS, Weinblatt ME, Shadick NA.

Ann Rheum Dis. 2008 Mar;67(3):358-63. Epub 2007 Jul 31.PMID: 17666451 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.

Potter C, Hyrich KL, Tracey A, Lunt M, Plant D, Symmons DP, Thomson W, Worthington J, Emery P, Morgan AW, Wilson AG, Isaacs J, Barton A; BRAGGSS.

Ann Rheum Dis. 2009 Jan;68(1):69-74. Epub 2008 Mar 28.PMID: 18375541 [PubMed - indexed for MEDLINE]Related articlesFree article

A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.

Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, Klareskog L, Dahlqvist SR.

Arthritis Res Ther. 2004;6(4):R303-8. Epub 2004 May 11.PMID: 15225365 [PubMed - indexed for MEDLINE]Related articlesFree article

Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.

Innala L, Kokkonen H, Eriksson C, Jidell E, Berglin E, Dahlqvst SR.

J Rheumatol. 2008 Jun;35(6):1002-8. Epub 2008 Apr 1.PMID: 18398946 [PubMed - indexed for MEDLINE]Related articles

The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.

Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ.

Scand J Rheumatol. 2008 May-Jun;37(3):183-7.PMID: 18465452 [PubMed - indexed for MEDLINE]Related articles

Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis.

Liao KP, Gunnarsson M, Källberg H, Ding B, Plenge RM, Padyukov L, Karlson EW, Klareskog L, Askling J, Alfredsson L.

Arthritis Rheum. 2009 Mar;60(3):653-60.PMID: 19248096 [PubMed - indexed for MEDLINE]Related articlesFree article

Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population.

Morgan AW, Thomson W, Martin SG; Yorkshire Early Arthritis Register Consortium, Carter AM; UK Rheumatoid Arthritis Genetics Consortium, Erlich HA, Barton A, Hocking L, Reid DM, Harrison P, Wordsworth P, Steer S, Worthington J, Emery P, Wilson AG, Barrett JH.

Arthritis Rheum. 2009 Sep;60(9):2565-76.PMID: 19714585 [PubMed - indexed for MEDLINE]Related articles

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.

van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, van Venrooij WJ, Verweij CL, Toes RE, de Vries RR.

Arthritis Rheum. 2004 Jul;50(7):2113-21.PMID: 15248208 [PubMed - indexed for MEDLINE]Related articlesFree article

Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.

Irigoyen P, Lee AT, Wener MH, Li W, Kern M, Batliwalla F, Lum RF, Massarotti E, Weisman M, Bombardier C, Remmers EF, Kastner DL, Seldin MF, Criswell LA, Gregersen PK.

Arthritis Rheum. 2005 Dec;52(12):3813-8.PMID: 16320316 [PubMed - indexed for MEDLINE]Related articlesFree article

The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population.

Chabchoub G, Teixiera EP, Maalej A, Ben Hamad M, Bahloul Z, Cornelis F, Ayadi H.

Ann Hum Biol. 2009 May-Jun;36(3):342-9.PMID: 19343596 [PubMed - indexed for MEDLINE]Related articles

Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients.

Pierer M, Kaltenhäuser S, Arnold S, Wahle M, Baerwald C, Häntzschel H, Wagner U.

Arthritis Res Ther. 2006;8(3):R75. Epub 2006 Apr 24.PMID: 16635271 [PubMed - indexed for MEDLINE]Related articlesFree article

Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.

Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S.

Ann Rheum Dis. 2006 Apr;65(4):453-8. Epub 2005 Sep 21.PMID: 16176994 [PubMed - indexed for MEDLINE]Related articlesFree article